Huabio Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Huabio General Information

Description

Provider and developer of the bioassay technology intended to serve the biotechnology. The company is mainly focused on the research and development of recombinant antibody development for monoclonal B cell screening, providing clients with industry-leading standard products and services.

Contact Information

Website
www.huabio.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room D1601, Building 2, No. 452
  • No. 6 Street, Baiyang Street, Qiantang District
  • Hangzhou, Zhejiang 310020
  • China
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Room D1601, Building 2, No. 452
  • No. 6 Street, Baiyang Street, Qiantang District
  • Hangzhou, Zhejiang 310020
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huabio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 25-Mar-2024 Completed Generating Revenue
To view Huabio’s complete valuation and funding history, request access »

Huabio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sanjie Investment Group Venture Capital Minority
Yongxi Assets Asset Manager Minority
To view Huabio’s complete investors history, request access »

Huabio Investments (1)

Huabio’s most recent deal was a Seed Round with AceLink for . The deal was made on 28-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AceLink 28-Jul-2019 Seed Round Drug Discovery
To view Huabio’s complete investments history, request access »

Huabio FAQs

  • When was Huabio founded?

    Huabio was founded in 2007.

  • Where is Huabio headquartered?

    Huabio is headquartered in Hangzhou, China.

  • What industry is Huabio in?

    Huabio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Huabio a private or public company?

    Huabio is a Private company.

  • What is Huabio’s current revenue?

    The current revenue for Huabio is .

  • Who are Huabio’s investors?

    Sanjie Investment Group and Yongxi Assets have invested in Huabio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process